Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Haematology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Haematology Other
    Community Practice Study Confirms Association Between ESAs, Venous Thromboembolism - (DGNews)
    X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) - (N Engl J Med)
    New USP Standards for Heparin Products Will Result in Decreased Potency - (DGNews)
    Thrombomodulin mutations in atypical hemolytic-uremic syndrome - (N Engl J Med)

    News archive

     Recent webcasts/CME - Haematology Other
    • Managing Treatment- and Disease-Related Complications in Multiple Myeloma
    • Thrombosis in Multiple Myeloma: Choice of Thromboprophylaxis Depends on Type of Therapy and Individual Risk of Patient
    • Evolving Strategies for Chronic Idiopathic Thrombocytepenic Purpura
      PreAnesthetic Assessment of the Patient on Low Dose Aspirin and a Thienopyridine - Part 2
      PreAnesthetic Assessment of the Patient on Low Dose Aspirin and a Thienopyridine - Part 1

      Webcasts/CME archive

       Recent cases - Haematology Other
        Cobalamin Deficiency Resulting in a Rare Haematological Disorder: A Case Report
        Complications of Evans' Syndrome in an Infant with Hereditary Spherocytosis: A Case Report
        Multisystem Failure Due to Three Coexisting Autoimmune Diseases
        An Unusual Cause of Methaemoglobinaemia
        Vancomycin-Induced Thrombocytopenia in a 60-Year-Old Man: A Case Report

        Cases archive
          




        my personal edition > haematology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Postoperative Anticoagulation Therapy Necessary in Patients Following Major Surgery: Presented at ASA

        By Lexa W. Lee

        NEW ORLEANS -- October 18, 2009 -- Timely postoperative anticoagulation therapy is a surgical necessity, according to results of a new study presented at the 2009 Annual Meeting of the American Society of Anesthesologists (ASA). Most procoagulant factors increase significantly within the first 6 days after major surgery, the study determined.

        Postoperative hypercoagulability is thought to be due to a reactive upregulation of the clotting system, although its time response has not been well investigated, explained lead investigator Susanne Lison MD, anaesthesiologist, University Hospital of Munich, Munich, Germany, speaking here on October 17. The goal of this study was to describe postoperative clotting changes in patients who have had major surgery, she noted.

        There were 33 patients in the study (20 male). The mean age was 65 years. The researchers included patients undergoing elective major surgery associated with a risk of bleeding, such as abdominal, oral, and gynaecological tumour surgery, as well as vascular operations.

        Blood samples were taken before surgery and every morning for 6 days postoperatively.

        Prothrombin time, activated partial prothrombin time (aPTT), and their associated clotting factors (fibrinogen and von Willebrand factor antigen [VWF AG]) were analysed.

        The mean preoperative VWF AG value was 176% +- 65%. On postoperative day 1, there was a marked increase to 240% +- 82%; on postoperative day 3, it reached a peak of 308% +- 82% (all values P < .05).

        The mean preoperative plasma level of fibrinogen was 354 mg/dL +- 91 mg/dL. On postoperative day 2, there was a significant increase to 484 mg/dL +- 79 mg/dL; on postoperative day 3, it reached a peak of 504 mg/dL +- 69 mg/dL (all values P < .05).

        The mean preoperative level of Factor VIII was 119% +- 38%. On postoperative day 2, there was a significant increase to 148% +- 40%; on postoperative day 6, it reached a peak of 163% +- 29% (all values P < .05).

        The mean preoperative level of Factor IX was 112% +- 25%. On postoperative day 3, there was a significant increase to 140% +- 24%; on postoperative day 6, it reached a peak of 155% +- 23% (all values P < .05).

        Factors II, VII, and X decreased significantly by approximately 20% on postoperative days 1 and 2, while there was an insignificant decrease of about 10% in PT. There were no significant changes in aPTT.

        The researchers concluded that there is a need for early postoperative anticoagulation measures in these patients based on the significant increase in most clotting factors in the first 6 days following major surgery, starting as early as postoperative day 2.

        [Presentation title: Postoperative Hemostasis in Patients Undergoing Major Surgery. Abstract A60]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send